Letters sent to healthcare professionals in November 2017

Letters were sent about eluxadoline (Truberzi), fingolimod (Gilenya), Bleo-Kyowa (bleomycin sulphate), Buccolam (midazolam), and ERWINASE.

In November 2017, the following letters were sent to relevant healthcare professionals to inform them of updated safety information:

Article citation: Drug Safety Update volume 11, issue 5; December 2017: 7.

Published 14 December 2017